Marshall Wace’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.34M | Sell |
162,133
-136,844
| -46% | -$1.97M | ﹤0.01% | 1376 |
|
|
2025
Q1 | $2.06M | Buy |
+298,977
| New | +$2.06M | ﹤0.01% | 1360 |
|
|
2024
Q3 | – | Sell |
-20,577
| Closed | -$56.2K | – | 2838 |
|
|
2024
Q2 | $56.2K | Buy |
+20,577
| New | +$56.2K | ﹤0.01% | 2219 |
|
|
2023
Q2 | – | Sell |
-34,600
| Closed | -$52.9K | – | 2618 |
|
|
2023
Q1 | $52.9K | Sell |
34,600
-47,492
| -58% | -$72.7K | ﹤0.01% | 2033 |
|
|
2022
Q4 | $138K | Hold |
82,092
| – | – | ﹤0.01% | 2160 |
|
|
2022
Q3 | $101K | Buy |
82,092
+32,641
| +66% | +$40.2K | ﹤0.01% | 2413 |
|
|
2022
Q2 | $83K | Sell |
49,451
-28,620
| -37% | -$48K | ﹤0.01% | 2571 |
|
|
2022
Q1 | $193K | Buy |
+78,071
| New | +$193K | ﹤0.01% | 2401 |
|
|
2021
Q4 | – | Sell |
-88,868
| Closed | -$557K | – | 3667 |
|
|
2021
Q3 | $557K | Buy |
88,868
+10,140
| +13% | +$63.6K | ﹤0.01% | 1807 |
|
|
2021
Q2 | $776K | Sell |
78,728
-184,114
| -70% | -$1.81M | ﹤0.01% | 1500 |
|
|
2021
Q1 | $2.46M | Buy |
+262,842
| New | +$2.46M | 0.01% | 1056 |
|